Details of the Drug
General Information of Drug (ID: DMDCQAX)
Drug Name |
4-amino-3,5-dibromobenzenesulfonamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-amino-3,5-dibromobenzenesulfonamide; 39150-45-3; 3,5-Dibromosulfanilamide; 2,6-Dibromosulfanilamide; 3,5-Dibromosulphanilamide; CHEMBL306195; DLXJPWSYRLLYSV-UHFFFAOYSA-N; AK109126; 4-amino-3,5-dibromobenzene-1-sulfonamide; Benzenesulfonamide, 4-amino-3,5-dibromo-; W-202619; EINECS 254-321-8; 4-Amino-3,5-dibromobenzenesulphonamide; ACMC-209j3o; AC1Q50HX; AC1MJ34Y; halogenosulfanilamide deriv. 12; SCHEMBL11136228; BDBM11611; CTK4I0998; DTXSID20192395; MolPort-001-780-206; ZINC2146706; ALBB-026584; ZX-AN025095; KS-00000NE9; 5104AB
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 330 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||